bioAffinity
  • Home
  • Publications
  • News
  • About Us
  • Videos
  • Contact
  • Investor Relations
  • Careers
Select Page

bioAffinity Technologies Attends NAVREF Industry Partner Quarterly Meeting

by Maria Zannes | Jun 12, 2023 | Events

bioAffinity Technologies President and CEO Maria Zannes is attending the National Association of Veterans’ Research and Education Foundations’ (NAVREF) quarterly meeting of industry partners in Portland, OR, June 12-13. NAVREF is a non-profit organization dedicated to...

bioAffinity Technologies Holds Annual Meeting of Stockholders

by Maria Zannes | Jun 6, 2023 | Events

bioAffinity Technologies, Inc. held its 2023 Annual Meeting of Stockholders on June 6, 2023, both in person at the Company’s principal office in San Antonio, TX, and virtually via a live webcast on June 6, 2023. Shareholders were entitled to cast one vote per share of...

bioAffinity CEO Will Be Featured Speaker at AGC Luncheon April 25

by Maria Zannes | Apr 18, 2023 | Events

APRIL 18, 2023 bioAffinity Technologies President and CEO Maria Zannes will address the Austin/San Antonio chapter of the Association for Corporate Growth (ACG) at a luncheon event on Tuesday, April 25, 2023. ACG is a global community for middle-market dealmakers and...

bioAffinity CEO To Moderate Health Cell Panel on Resources for Start-Ups

by Maria Zannes | Mar 6, 2023 | Events

MARCH 6, 2023 You’ve developed a great healthcare/life science idea, discovered a market for it and launched your business. Now what? The Health Cell’s monthly meeting Thursday, March 9, 2023, from 11:30 a.m. to 1 p.m. at the La Quinta Wyndham San Antonio Medical...

bioAffinity President & CEO to meet with institutional investors and bankers during J.P. Morgan Annual Healthcare Conference in San Francisco, January 9-12, 2023

by Dale Harrison | Dec 28, 2022 | Events

December 30, 2022 bioAffinity President & CEO Maria Zannes will meet with the institutional investors and investment banking groups while attending the WuXi Global Forum “Advancing Breakthroughs for Patients” during the J.P. Morgan 41st Annual Healthcare...

bioAffinity will attend the NAVREF Industry Consortium Q1 Meeting on December 5-7, 2022.

by Dale Harrison | Dec 1, 2022 | Events

December 1, 2022 bioAffinity will attend the NAVREF Industry Consortium Q1 Meeting on December 5-7, 2022 in Miami Florida. About The IPC Meeting for FY23 Q1 This day-and-a-half meeting is designed to be an opportunity to launch our efforts in 2023. ...
« Older Entries

Categories

  • Articles (27)
  • Events (38)
  • News (52)
  • Press Releases (122)
  • Publications (17)

Recent Posts

  • bioAffinity Technologies Announces New U.S. Patent for Novel Broad Spectrum Cancer Therapeutics May 28, 2025
  • bioAffinity Technologies Appoints Dr. Gordon Downie, MD, PhD, as Chief Medical Officer May 20, 2025
  • bioAffinity Technologies Reports First Quarter 2025 Results May 15, 2025
  • Independent White Paper Highlights Real-World Impact of bioAffinity Technologies’ CyPath® Lung in Diagnosing Early-Stage Lung Cancer May 8, 2025
  • bioAffinity Technologies Announces Closing of $3.25 Million Offering May 7, 2025

Learn About CyPath Lung

CyPath Lung Test

Main Menu

  • Home
  • Publications
  • News
  • About Us
  • Videos
  • Contact
  • Investor Relations
  • Careers
Copyright © 2023 bioAffinity Technologies, Inc.